Reply
Hitendra Garg, Shiv Kumar Sarin, Manoj Kumar, Vishal Garg, Barjesh Chander Sharma, Ashish Kumar – 23 May 2011
Association of the cannabinoid receptor 2 (CB2) Gln63Arg polymorphism with indices of liver damage in obese children: An alternative way to highlight the CB2 hepatoprotective properties
Francesca Rossi, Giulia Bellini, Bruno Nobili, Sabatino Maione, Laura Perrone, Emanuele Miraglia del Giudice – 23 May 2011
Stem cells or macrophages: Which contribute to bone marrow cell therapy for liver cirrhosis?
Tao Liu, Yingjie Wang, Chenting Wen, Shichang Zhang, Chunmei Zhang – 23 May 2011
MicroRNAs‐372/373 promote the expression of hepatitis B virus through the targeting of nuclear factor I/B
Hongyan Guo, Haiying Liu, Keith Mitchelson, Huiying Rao, Mingyong Luo, Lan Xie, Yimin Sun, Liang Zhang, Ying Lu, Ruyu Liu, Aihui Ren, Shuai Liu, Shaozhen Zhou, Jiye Zhu, Yuxiang Zhou, Ailong Huang, Lai Wei, Yong Guo, Jing Cheng – 23 May 2011 – MicroRNAs (miRNAs) play important roles in the posttranscriptional regulation of gene expression. Recent evidence has indicated the pathological relevance of miRNA dysregulation in hepatitis virus infection; however, the roles of microRNAs in the regulation of hepatitis B virus (HBV) expression are still largely unknown.
Saffron: A potential candidate for a novel anticancer drug against hepatocellular carcinoma
Amr Amin, Alaaeldin A. Hamza, Khuloud Bajbouj, S. Salman Ashraf, Sayel Daoud – 23 May 2011 – Saffron has been proposed as a promising candidate for cancer chemoprevention. The purpose of this investigation was to investigate the chemopreventive action and the possible mechanisms of saffron against diethylnitrosamine (DEN)‐induced liver cancer in rats. Administration of saffron at doses of 75, 150, and 300 mg/kg/day was started 2 weeks prior to the DEN injection and was continued for 22 weeks.
Absence of occult hepatitis C virus infection in patients under immunosupressive therapy for oncohematological diseases
Nicola Coppola, Mariantonietta Pisaturo, Salvatore Guastafierro, Gilda Tonziello, Antonello Sica, Caterina Sagnelli, Maria Giovanna Ferrara, Evangelista Sagnelli – 23 May 2011
Metabolic syndrome and liver cancer: Is excess iron the link?
Luca Mascitelli, Mark R. Goldstein – 23 May 2011
Autologous bone marrow mesenchymal stem cell transplantation in liver failure patients caused by hepatitis B: Short‐term and long‐term outcomes
Liang Peng, Dong‐ying Xie, Bing‐Liang Lin, Jing Liu, Hai‐peng Zhu, Chan Xie, Yu‐bao Zheng, Zhi‐liang Gao – 23 May 2011 – Our study aimed to investigate the short‐term efficacy and long‐term prognosis of liver failure patients caused by hepatitis B after a single transplantation with autologous marrow mesenchymal stem cells (MMSCs). A total of 527 inpatients with liver failure caused by hepatitis B were recruited and received the same medical treatments, among whom 53 patients underwent a single transplantation with autologous MMSCs.
Raised sympathetic activity and blood ammonia could increase sensitivity to infections in patients with cirrhosis and refractory ascites who are using beta‐blockers
Georgios N. Kalambokis, Epameinondas V. Tsianos – 23 May 2011